The University of Chicago Header Logo

Stephen Hanauer

Concepts (935)

Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.


Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Crohn Disease
215
2024
765
27.160
Why?
Colitis, Ulcerative
175
2024
763
20.360
Why?
Inflammatory Bowel Diseases
84
2025
599
16.140
Why?
Gastrointestinal Agents
53
2024
174
10.020
Why?
Anti-Inflammatory Agents, Non-Steroidal
48
2021
243
6.830
Why?
Anti-Inflammatory Agents
50
2020
348
6.570
Why?
Immunosuppressive Agents
65
2021
984
6.560
Why?
Antibodies, Monoclonal
71
2024
1397
6.470
Why?
Mesalamine
45
2020
88
6.420
Why?
Gastroenterology
14
2020
149
4.410
Why?
Remission Induction
77
2024
745
3.950
Why?
Infliximab
53
2024
159
3.760
Why?
Tumor Necrosis Factor-alpha
43
2023
705
3.700
Why?
Humans
488
2025
90539
3.660
Why?
Biological Therapy
16
2020
47
3.550
Why?
Biosimilar Pharmaceuticals
5
2024
25
3.520
Why?
Colitis
13
2024
249
3.430
Why?
Biological Products
13
2023
166
3.290
Why?
Azathioprine
22
2021
124
3.140
Why?
Adalimumab
23
2024
89
2.920
Why?
Treatment Outcome
129
2024
8367
2.900
Why?
Immunologic Factors
14
2021
172
2.830
Why?
Severity of Illness Index
64
2024
1882
2.710
Why?
Aminosalicylic Acids
29
2016
41
2.690
Why?
Double-Blind Method
84
2024
1723
2.550
Why?
Stress Disorders, Post-Traumatic
5
2023
116
2.360
Why?
Adrenal Cortex Hormones
26
2024
276
2.270
Why?
Mercaptopurine
13
2018
53
2.230
Why?
Adult
198
2024
26922
2.090
Why?
Antibodies, Monoclonal, Humanized
38
2024
962
1.990
Why?
Female
216
2024
46831
1.840
Why?
Male
205
2024
42909
1.800
Why?
Sulfasalazine
18
2016
34
1.770
Why?
Clinical Trials as Topic
24
2024
1141
1.750
Why?
Maintenance Chemotherapy
14
2024
84
1.750
Why?
Glucocorticoids
20
2024
359
1.730
Why?
Colonoscopy
24
2021
281
1.730
Why?
Ustekinumab
9
2023
52
1.720
Why?
Arthritis, Rheumatoid
5
2023
172
1.710
Why?
Intestinal Mucosa
25
2020
807
1.700
Why?
Methotrexate
12
2022
244
1.690
Why?
Colorectal Neoplasms
15
2024
974
1.670
Why?
Middle Aged
150
2024
26305
1.620
Why?
Drug Therapy, Combination
27
2023
792
1.600
Why?
Pharmaceutical Preparations
3
2021
93
1.580
Why?
Induction Chemotherapy
12
2023
153
1.520
Why?
Cyclosporine
13
2018
239
1.510
Why?
Smoking
15
2020
627
1.470
Why?
Colectomy
22
2018
175
1.460
Why?
Digestive System Diseases
6
2010
18
1.430
Why?
Diarrhea
9
2021
178
1.330
Why?
Biomedical Research
7
2010
403
1.320
Why?
Drug Monitoring
8
2020
118
1.320
Why?
Fellowships and Scholarships
2
2020
129
1.270
Why?
Drug Industry
4
2009
54
1.180
Why?
Randomized Controlled Trials as Topic
23
2024
845
1.180
Why?
Pyrimidines
2
2021
371
1.130
Why?
Colon
25
2020
522
1.110
Why?
Nicotine
8
2012
202
1.100
Why?
Secondary Prevention
9
2020
162
1.100
Why?
Education, Medical, Graduate
2
2020
406
1.060
Why?
United States
37
2024
7138
1.050
Why?
Quality of Life
26
2024
1687
1.020
Why?
Budesonide
10
2016
46
1.010
Why?
Drug-Related Side Effects and Adverse Reactions
5
2022
203
1.010
Why?
Immunoglobulin Fab Fragments
10
2014
85
1.000
Why?
Anti-Infective Agents
8
2013
91
0.970
Why?
Serum
2
2015
25
0.970
Why?
Vitamin D
4
2016
269
0.960
Why?
Dose-Response Relationship, Drug
38
2022
1935
0.950
Why?
Evidence-Based Medicine
8
2011
440
0.940
Why?
Certolizumab Pegol
11
2016
19
0.940
Why?
Safety
9
2021
144
0.940
Why?
Loperamide
4
2008
7
0.930
Why?
Anti-Bacterial Agents
15
2011
806
0.930
Why?
Drug Administration Schedule
23
2020
866
0.930
Why?
Antidiarrheals
4
2008
14
0.920
Why?
Biomarkers
14
2024
1797
0.910
Why?
Polyethylene Glycols
10
2014
361
0.900
Why?
Health Care Reform
3
2010
85
0.890
Why?
Semen
2
2022
13
0.870
Why?
Allopurinol
5
2018
78
0.860
Why?
Travel
3
2010
73
0.860
Why?
Drug Resistance
13
2014
232
0.850
Why?
Irritable Bowel Syndrome
3
2008
46
0.850
Why?
Janus Kinase Inhibitors
1
2023
23
0.840
Why?
Nicotinic Agonists
3
2012
75
0.830
Why?
Semen Analysis
1
2022
2
0.820
Why?
Risk Assessment
13
2019
2335
0.820
Why?
Practice Guidelines as Topic
11
2016
1054
0.810
Why?
Precision Medicine
2
2025
413
0.810
Why?
Piperidines
3
2021
163
0.800
Why?
Aged
71
2024
19380
0.800
Why?
Placebos
12
2018
211
0.790
Why?
Atrioventricular Block
1
2022
26
0.780
Why?
Europe
9
2023
328
0.760
Why?
Diet, Mediterranean
1
2021
5
0.760
Why?
Oxadiazoles
5
2024
38
0.760
Why?
Indans
5
2024
35
0.750
Why?
Gastrointestinal Diseases
4
2024
151
0.750
Why?
Polymorphism, Genetic
2
2025
827
0.750
Why?
Pyrroles
2
2021
173
0.750
Why?
Prodrugs
4
2013
52
0.740
Why?
Young Adult
37
2024
6412
0.740
Why?
Colonic Neoplasms
11
2018
571
0.730
Why?
Injections, Subcutaneous
9
2024
124
0.720
Why?
Adolescent
55
2021
9341
0.720
Why?
Recurrence
22
2020
1162
0.720
Why?
Time Factors
34
2024
5364
0.710
Why?
Patient Selection
8
2011
682
0.710
Why?
Steroids
12
2011
173
0.710
Why?
Diagnostic Imaging
4
2014
476
0.710
Why?
Competency-Based Education
1
2020
38
0.700
Why?
C-Reactive Protein
14
2022
196
0.690
Why?
Precancerous Conditions
4
2016
201
0.690
Why?
Global Health
5
2011
192
0.680
Why?
Psychopathology
1
2019
30
0.660
Why?
alpha-Fetoproteins
1
2019
44
0.650
Why?
Antibodies
10
2016
353
0.650
Why?
Diet
4
2021
447
0.650
Why?
Administration, Oral
18
2016
671
0.640
Why?
Time-to-Treatment
1
2020
125
0.640
Why?
Gastrointestinal Tract
2
2014
192
0.620
Why?
Conflict of Interest
3
2009
68
0.610
Why?
Purines
1
2018
93
0.600
Why?
Chronic Disease
10
2022
959
0.600
Why?
Follow-Up Studies
22
2019
3691
0.590
Why?
Health Care Costs
3
2009
237
0.590
Why?
Primary Prevention
2
2008
82
0.570
Why?
Antineoplastic Agents, Immunological
1
2020
205
0.570
Why?
Vitamin D Deficiency
3
2016
104
0.550
Why?
Ulcer
3
2006
37
0.550
Why?
Interleukin-23
1
2017
57
0.540
Why?
Anti-Ulcer Agents
4
2005
22
0.540
Why?
Prognosis
20
2020
3810
0.540
Why?
Drug Approval
2
2007
65
0.540
Why?
Food
3
2021
89
0.540
Why?
Risk Factors
22
2021
5578
0.540
Why?
Sigmoidoscopy
11
2015
36
0.530
Why?
Cholangitis, Sclerosing
5
2020
51
0.520
Why?
Enema
7
2008
39
0.520
Why?
Gastrointestinal Hemorrhage
4
2020
241
0.520
Why?
Trichuris
2
2013
2
0.510
Why?
Proctocolectomy, Restorative
2
2012
105
0.510
Why?
Enterocolitis
2
2022
13
0.490
Why?
Wound Healing
8
2020
365
0.480
Why?
Granulocytes
2
2012
38
0.480
Why?
Blood Component Removal
2
2012
25
0.480
Why?
Infusions, Intravenous
15
2016
419
0.470
Why?
Academic Medical Centers
2
2009
387
0.470
Why?
Delayed-Action Preparations
9
2016
111
0.470
Why?
Pneumonia
2
2015
184
0.460
Why?
History, 20th Century
5
2012
315
0.460
Why?
Patient Satisfaction
5
2011
463
0.460
Why?
Clinical Competence
3
2020
796
0.460
Why?
Metabolic Syndrome
2
2006
124
0.460
Why?
Monocytes
4
2012
222
0.450
Why?
Delivery of Health Care
2
2009
431
0.450
Why?
Diverticulitis
1
2013
10
0.450
Why?
Societies, Medical
2
2015
591
0.440
Why?
Research Design
7
2024
590
0.440
Why?
Intestinal Polyps
2
2008
27
0.440
Why?
Therapy with Helminths
1
2013
1
0.440
Why?
Antigens, Helminth
1
2013
22
0.430
Why?
Tacrolimus
3
2011
371
0.430
Why?
Diverticulum
1
2013
45
0.430
Why?
Ovum
1
2013
60
0.420
Why?
Life Style
3
2008
174
0.420
Why?
Ileostomy
3
2012
29
0.420
Why?
Antimetabolites
4
2011
24
0.420
Why?
Treatment Refusal
3
2011
62
0.410
Why?
Thioguanine
5
2018
17
0.410
Why?
Obesity
4
2008
974
0.410
Why?
Radiation Injuries
2
2014
159
0.410
Why?
Hospitalization
6
2024
898
0.410
Why?
Population Surveillance
5
2016
209
0.400
Why?
Disease Progression
7
2024
1485
0.400
Why?
Allergens
1
2013
183
0.400
Why?
Surgical Stomas
1
2012
22
0.400
Why?
Carnitine
1
2012
14
0.400
Why?
Biomarkers, Tumor
3
2019
1547
0.400
Why?
Postoperative Complications
8
2018
2341
0.390
Why?
Colonic Polyps
2
2018
132
0.390
Why?
Intestinal Fistula
5
2016
31
0.390
Why?
History, 21st Century
4
2012
185
0.380
Why?
Colonic Diseases, Functional
3
2003
3
0.380
Why?
Biological Factors
3
2019
18
0.380
Why?
Health Promotion
3
2008
164
0.370
Why?
Vitamins
2
2016
83
0.370
Why?
Pregnancy
12
2019
3064
0.370
Why?
Disease Outbreaks
2
2009
156
0.360
Why?
Biopsy
11
2020
1192
0.360
Why?
Endoscopy, Gastrointestinal
7
2013
163
0.360
Why?
Physicians
2
2009
690
0.360
Why?
Case-Control Studies
16
2023
1873
0.360
Why?
Neutrophils
3
2024
313
0.360
Why?
Hypertension, Portal
1
2010
46
0.350
Why?
Inflammation
7
2023
990
0.350
Why?
Leukapheresis
3
2008
20
0.350
Why?
Otitis Media
1
2010
20
0.340
Why?
Health Behavior
2
2009
181
0.340
Why?
Cephalosporins
1
2010
24
0.340
Why?
Prednisolone
3
2018
40
0.340
Why?
Education, Medical, Continuing
2
2011
106
0.340
Why?
Peptic Ulcer
1
2009
18
0.330
Why?
Self Disclosure
1
2009
32
0.330
Why?
Proctitis
2
2000
12
0.330
Why?
Esophagitis
1
2009
43
0.330
Why?
Safety Management
1
2009
56
0.330
Why?
Specialization
1
2010
70
0.330
Why?
Outsourced Services
1
2009
1
0.330
Why?
Consumer Product Safety
1
2009
11
0.330
Why?
Commerce
1
2009
31
0.330
Why?
Proton Pump Inhibitors
1
2009
34
0.330
Why?
Body Temperature Regulation
1
2009
57
0.320
Why?
Financial Support
1
2009
7
0.320
Why?
Food Contamination
1
2009
34
0.320
Why?
Food Supply
1
2009
29
0.320
Why?
Uncertainty
2
2021
75
0.320
Why?
Adipose Tissue, Brown
1
2009
89
0.320
Why?
Sulfapyridine
1
2008
2
0.310
Why?
Abdominal Pain
2
2007
142
0.310
Why?
Jet Lag Syndrome
1
2008
13
0.310
Why?
Muscle Hypotonia
1
2009
50
0.310
Why?
Drug Delivery Systems
2
2007
179
0.300
Why?
Surveys and Questionnaires
11
2019
2667
0.300
Why?
Happiness
1
2008
12
0.300
Why?
Histamine Antagonists
1
2008
13
0.300
Why?
Task Performance and Analysis
1
2008
88
0.300
Why?
Periodicals as Topic
1
2010
168
0.300
Why?
Self Efficacy
1
2008
58
0.300
Why?
Risk Reduction Behavior
1
2008
96
0.300
Why?
Prospective Studies
20
2024
4345
0.300
Why?
Marketing
1
2008
23
0.300
Why?
Prevalence
6
2022
1251
0.290
Why?
Prednisone
8
2007
254
0.290
Why?
Behavior
1
2008
84
0.290
Why?
Legislation as Topic
1
2007
3
0.290
Why?
Ileal Diseases
2
2004
26
0.290
Why?
Fasting
1
2008
166
0.290
Why?
Cost-Benefit Analysis
4
2021
471
0.290
Why?
Retrospective Studies
24
2020
9310
0.290
Why?
Neoplasms
5
2024
3029
0.290
Why?
Measles-Mumps-Rubella Vaccine
1
2007
7
0.290
Why?
Immunity, Innate
2
2014
437
0.290
Why?
Clinical Trials, Phase I as Topic
1
2008
152
0.290
Why?
Feces
4
2021
335
0.290
Why?
Antirheumatic Agents
4
2011
60
0.290
Why?
Gastroesophageal Reflux
1
2009
126
0.290
Why?
Simethicone
1
2007
1
0.290
Why?
Flatulence
1
2007
2
0.290
Why?
Health Priorities
1
2007
22
0.290
Why?
Terminology as Topic
2
2011
223
0.290
Why?
Animals
16
2025
27690
0.290
Why?
Retreatment
5
2016
107
0.290
Why?
Gastrointestinal Motility
1
2007
25
0.280
Why?
Quality of Health Care
2
2012
387
0.280
Why?
Nutritional Physiological Phenomena
1
2007
27
0.280
Why?
Diagnosis, Differential
8
2010
1607
0.280
Why?
Liver Diseases
2
2008
242
0.280
Why?
Nutrition Assessment
1
2007
20
0.280
Why?
Energy Metabolism
1
2009
287
0.280
Why?
Economic Competition
1
2006
12
0.280
Why?
Patents as Topic
1
2006
12
0.280
Why?
Insemination, Artificial, Homologous
1
2006
4
0.280
Why?
Immunity
1
2008
141
0.270
Why?
Ethics, Medical
1
2009
306
0.270
Why?
Ovulation Induction
1
2006
31
0.270
Why?
Phosphodiesterase Inhibitors
1
2006
30
0.270
Why?
Abdominal Abscess
2
2016
23
0.270
Why?
Drugs, Generic
1
2006
21
0.270
Why?
Occupational Health
1
2007
36
0.270
Why?
United States Food and Drug Administration
1
2007
135
0.270
Why?
Observation
1
2006
38
0.270
Why?
Nobel Prize
1
2006
10
0.270
Why?
Health Expenditures
1
2007
90
0.270
Why?
Biodiversity
1
2009
220
0.270
Why?
Autistic Disorder
1
2007
147
0.270
Why?
Infertility
1
2006
35
0.270
Why?
Contraceptives, Oral
3
1991
47
0.270
Why?
Self Concept
1
2007
135
0.260
Why?
Pandemics
2
2022
788
0.260
Why?
Integrins
3
2021
79
0.260
Why?
Ileum
7
2016
168
0.260
Why?
Disease Management
4
2018
332
0.260
Why?
Vibrio Infections
1
2005
2
0.260
Why?
Thiazoles
1
2006
127
0.260
Why?
Genetics
1
2006
24
0.260
Why?
Natalizumab
7
2013
21
0.260
Why?
Gastroenteritis
1
2005
26
0.250
Why?
Private Practice
1
2005
11
0.250
Why?
Cell Transformation, Neoplastic
2
2010
455
0.250
Why?
Climate
1
2005
60
0.250
Why?
Circadian Rhythm
1
2008
305
0.250
Why?
Spermatozoa
2
2022
62
0.250
Why?
Symptom Assessment
3
2020
68
0.250
Why?
Ethics Committees, Research
1
2005
34
0.250
Why?
Intestine, Small
6
2021
299
0.250
Why?
Unemployment
1
2005
10
0.250
Why?
Aged, 80 and over
12
2019
6808
0.250
Why?
Foodborne Diseases
1
2005
8
0.250
Why?
Human Experimentation
1
2005
39
0.240
Why?
Researcher-Subject Relations
1
2005
4
0.240
Why?
Stress, Psychological
1
2008
322
0.240
Why?
Journalism, Medical
1
2004
6
0.240
Why?
Pregnancy Complications
3
2004
343
0.240
Why?
Hyperbaric Oxygenation
1
2024
13
0.240
Why?
Peer Review
1
2004
22
0.240
Why?
Dietary Supplements
1
2005
124
0.240
Why?
Rectal Fistula
3
2014
18
0.240
Why?
Stem Cell Transplantation
1
2006
190
0.240
Why?
HLA-DR Antigens
1
2004
59
0.230
Why?
Ultrasonography
2
2018
722
0.230
Why?
Triggering Receptor Expressed on Myeloid Cells-1
1
2024
1
0.230
Why?
Ileitis
3
2011
7
0.230
Why?
Disability Evaluation
1
2005
140
0.230
Why?
Pain
2
2023
399
0.230
Why?
HLA-DQ Antigens
1
2004
51
0.230
Why?
Patient Reported Outcome Measures
2
2024
202
0.230
Why?
Intestines
3
2020
416
0.230
Why?
Serum Albumin
2
2019
128
0.230
Why?
Feeding Behavior
1
2007
330
0.230
Why?
Acute Disease
9
2011
854
0.230
Why?
Cell- and Tissue-Based Therapy
2
2015
57
0.230
Why?
MicroRNAs
4
2021
561
0.230
Why?
Career Choice
1
2005
148
0.230
Why?
Cecal Diseases
1
2003
5
0.230
Why?
Stents
1
2007
415
0.220
Why?
Vagus Nerve Stimulation
1
2023
10
0.220
Why?
Enterocolitis, Pseudomembranous
3
2011
52
0.220
Why?
Aging
1
2009
727
0.220
Why?
Osteoporosis
1
2005
122
0.220
Why?
Employment
1
2004
53
0.220
Why?
Congresses as Topic
3
2010
116
0.220
Why?
Adenocarcinoma
3
2018
1182
0.220
Why?
Lactoferrin
1
2003
10
0.220
Why?
Organ Transplantation
1
2007
285
0.220
Why?
DNA Breaks, Double-Stranded
2
2021
67
0.220
Why?
Lupus Vulgaris
1
2003
4
0.220
Why?
Intracellular Signaling Peptides and Proteins
4
2010
388
0.220
Why?
Fetus
1
2004
232
0.210
Why?
Lung Diseases
1
2005
276
0.210
Why?
Fibroblast Growth Factors
1
2003
82
0.210
Why?
Adjuvants, Immunologic
4
2009
169
0.210
Why?
Adipose Tissue
1
2005
263
0.210
Why?
Clinical Trials, Phase III as Topic
2
2018
168
0.210
Why?
Placenta
2
2015
182
0.210
Why?
Anus Diseases
2
2003
15
0.200
Why?
Incidence
8
2020
1593
0.200
Why?
Calcineurin Inhibitors
2
2013
53
0.200
Why?
Education, Medical
1
2005
244
0.200
Why?
Pentanoic Acids
1
2002
6
0.200
Why?
Cycloserine
1
2001
5
0.200
Why?
Genetic Predisposition to Disease
9
2010
2362
0.190
Why?
Chicago
4
2018
1441
0.190
Why?
DNA End-Joining Repair
1
2021
3
0.190
Why?
Graft Rejection
1
2007
1084
0.190
Why?
Carbohydrates
1
2021
48
0.190
Why?
Administration, Topical
4
2016
95
0.190
Why?
Language
1
2022
157
0.180
Why?
Interleukin-12
1
2021
111
0.180
Why?
CD3 Complex
3
2014
135
0.180
Why?
Symptom Flare Up
2
2021
12
0.180
Why?
Cell Adhesion Molecules
3
2024
166
0.180
Why?
Mycophenolic Acid
1
2001
84
0.180
Why?
Phenylhydrazines
5
2005
10
0.180
Why?
Chemoprevention
3
2006
92
0.180
Why?
Leukocyte L1 Antigen Complex
4
2023
49
0.180
Why?
DNA
3
2022
1314
0.170
Why?
Graft vs Host Disease
1
2022
362
0.170
Why?
Erythrocyte Count
1
2019
22
0.170
Why?
Ipilimumab
1
2020
60
0.170
Why?
Pyridines
1
2002
303
0.170
Why?
Hematocrit
1
2019
68
0.170
Why?
Logistic Models
5
2006
1216
0.170
Why?
Erythema Nodosum
2
2006
4
0.170
Why?
Genetic Linkage
5
2002
624
0.170
Why?
Thalidomide
1
1999
56
0.170
Why?
Pouchitis
2
2012
55
0.160
Why?
Platelet Count
1
2019
93
0.160
Why?
CTLA-4 Antigen
1
2020
140
0.160
Why?
Forecasting
3
2008
306
0.160
Why?
Psoriasis
1
2022
245
0.160
Why?
Indoles
3
2009
306
0.160
Why?
Neurons
1
2008
1593
0.160
Why?
Blood Proteins
1
2019
149
0.160
Why?
Lymphoproliferative Disorders
1
1999
111
0.160
Why?
Long-Term Care
4
2017
62
0.160
Why?
Hemoglobins
1
2019
195
0.160
Why?
Cardiovascular Diseases
1
2005
722
0.160
Why?
Rectum
6
2011
149
0.150
Why?
Treatment Failure
4
2014
281
0.150
Why?
Genomic Instability
1
2019
84
0.150
Why?
Programmed Cell Death 1 Receptor
1
2020
174
0.150
Why?
Menstrual Cycle
1
1998
58
0.150
Why?
Retroperitoneal Neoplasms
1
1998
44
0.150
Why?
Interleukin-6
2
2017
268
0.150
Why?
Stomatitis, Aphthous
1
1998
4
0.150
Why?
Sensitivity and Specificity
3
2010
2019
0.150
Why?
Autoimmune Diseases
2
2002
252
0.150
Why?
Prostatic Neoplasms
2
2020
1751
0.150
Why?
Pyoderma Gangrenosum
1
1998
19
0.150
Why?
Antineoplastic Combined Chemotherapy Protocols
5
2021
2519
0.150
Why?
Aspirin
1
2019
162
0.150
Why?
Fecal Incontinence
2
2008
59
0.150
Why?
B7-H1 Antigen
1
2020
279
0.150
Why?
Child
11
2013
7215
0.150
Why?
Thrombospondins
1
2017
14
0.140
Why?
Caveolin 1
1
2017
23
0.140
Why?
Parenteral Nutrition, Total
4
2005
41
0.140
Why?
Antibody Formation
2
2011
172
0.140
Why?
Standard of Care
1
2018
65
0.140
Why?
Pilot Projects
7
2013
878
0.140
Why?
Colonic Diseases
3
2006
61
0.140
Why?
Paternal Exposure
1
2017
3
0.140
Why?
Lymphoma, B-Cell
1
1998
110
0.140
Why?
Cohort Studies
4
2019
2893
0.140
Why?
Meta-Analysis as Topic
2
2009
82
0.140
Why?
Collagen Type I
1
2017
73
0.140
Why?
Legislation, Drug
2
2007
6
0.140
Why?
Reproducibility of Results
6
2024
2782
0.140
Why?
Tumor Microenvironment
1
2021
478
0.140
Why?
Practice Patterns, Physicians'
2
2016
604
0.140
Why?
Protein-Losing Enteropathies
1
1996
6
0.140
Why?
Injections, Intravenous
4
2018
238
0.140
Why?
Focal Adhesions
1
2017
70
0.140
Why?
Drug Design
1
2017
129
0.140
Why?
United Kingdom
3
2020
167
0.140
Why?
Placebo Effect
2
2014
31
0.130
Why?
Drug Synergism
2
2007
307
0.130
Why?
Fertility
1
2017
116
0.130
Why?
Leukoencephalopathy, Progressive Multifocal
2
2014
13
0.130
Why?
Lymphoma, Large B-Cell, Diffuse
1
1998
175
0.130
Why?
Cross-Over Studies
3
2009
387
0.130
Why?
Prostate-Specific Antigen
1
2018
343
0.130
Why?
Receptors, Lysosphingolipid
1
2016
37
0.130
Why?
Nod2 Signaling Adaptor Protein
4
2010
13
0.130
Why?
Algorithms
4
2014
1918
0.130
Why?
Gastrointestinal Microbiome
2
2020
526
0.130
Why?
Guidelines as Topic
2
2007
161
0.130
Why?
Receptors, Calcitriol
2
2016
130
0.130
Why?
Digestive System Fistula
3
2010
4
0.130
Why?
Clinical Decision-Making
1
2018
283
0.130
Why?
Transition to Adult Care
1
2016
22
0.130
Why?
Drug Combinations
2
2007
204
0.130
Why?
Reactive Oxygen Species
1
2019
493
0.130
Why?
Chi-Square Distribution
3
2007
360
0.130
Why?
Smoking Cessation
3
2012
264
0.130
Why?
Interleukin-12 Subunit p40
1
2015
12
0.130
Why?
Clinical Medicine
1
2015
34
0.120
Why?
Chromosomes, Human, Pair 16
3
2000
79
0.120
Why?
Integrin alpha4
3
2013
11
0.120
Why?
Lymphocytes
2
2015
470
0.120
Why?
Monitoring, Physiologic
3
2012
265
0.120
Why?
Digestive System Surgical Procedures
3
2005
131
0.120
Why?
T-Lymphocytes
4
2023
1228
0.120
Why?
Autoantibodies
1
1996
275
0.120
Why?
Cell Migration Inhibition
1
2014
8
0.120
Why?
Fistula
1
2014
42
0.110
Why?
Drug Substitution
1
2014
27
0.110
Why?
Radiation Protection
1
2014
27
0.110
Why?
Endoscopy
3
2013
353
0.110
Why?
Postoperative Period
3
2016
301
0.110
Why?
Oxides
1
2014
43
0.110
Why?
Aminosalicylic Acid
1
2013
1
0.110
Why?
Acute Kidney Injury
1
2018
319
0.110
Why?
Intestinal Obstruction
3
2006
89
0.110
Why?
Calcineurin
1
2013
20
0.110
Why?
Radiation, Ionizing
1
2014
124
0.110
Why?
Radiography, Thoracic
1
2015
327
0.110
Why?
Carbon
1
2014
93
0.110
Why?
Probiotics
2
2008
89
0.110
Why?
Cholangitis
1
1993
19
0.110
Why?
Mucous Membrane
1
2013
83
0.110
Why?
Vaginal Fistula
1
1993
5
0.110
Why?
Pulmonary Embolism
1
1996
237
0.110
Why?
Ciprofloxacin
1
2013
30
0.110
Why?
Observer Variation
4
2018
615
0.110
Why?
Occupational Exposure
1
2014
87
0.110
Why?
Enteritis
1
2013
21
0.100
Why?
Methyltransferases
3
2011
193
0.100
Why?
Pneumonia, Pneumocystis
1
1992
18
0.100
Why?
Consensus
2
2022
371
0.100
Why?
Defecation
2
2009
23
0.100
Why?
Gastritis
1
2013
36
0.100
Why?
Sickness Impact Profile
2
2011
26
0.100
Why?
Body Weight
1
2013
455
0.100
Why?
Sigmoid Diseases
1
1992
4
0.100
Why?
Intestinal Pseudo-Obstruction
1
1992
6
0.100
Why?
Abatacept
1
2012
86
0.100
Why?
Guanine Nucleotides
1
2011
14
0.100
Why?
Bacterial Infections
2
2006
185
0.100
Why?
Thionucleotides
1
2011
55
0.100
Why?
Quality Indicators, Health Care
1
2013
149
0.090
Why?
Phenotype
5
2021
2467
0.090
Why?
Cytomegalovirus
1
2011
82
0.090
Why?
Proto-Oncogenes
1
2011
61
0.090
Why?
Immunoconjugates
1
2012
115
0.090
Why?
Attitude
1
2012
130
0.090
Why?
Age Factors
4
2007
1871
0.090
Why?
Odds Ratio
5
2003
680
0.090
Why?
Tomography, X-Ray Computed
2
2015
2692
0.090
Why?
Chromosomes, Human, Pair 3
2
2002
54
0.090
Why?
Carcinoma
2
1995
438
0.090
Why?
Capsules
6
2002
38
0.090
Why?
Patient Acuity
2
2020
35
0.090
Why?
Enzyme Inhibitors
1
2013
651
0.090
Why?
Cytomegalovirus Infections
1
2011
153
0.090
Why?
Liver
3
2011
1216
0.090
Why?
Reference Values
2
2018
662
0.090
Why?
Receptors, Tumor Necrosis Factor
2
2001
90
0.090
Why?
Analysis of Variance
4
2002
898
0.090
Why?
Writing
1
2010
29
0.090
Why?
Mexico
1
2010
70
0.090
Why?
Interleukin-10
2
2000
155
0.090
Why?
Editorial Policies
1
2010
34
0.080
Why?
Leukemia, Myeloid
3
1995
249
0.080
Why?
Cross-Cultural Comparison
1
2009
34
0.080
Why?
Folic Acid Deficiency
1
1989
7
0.080
Why?
Reoperation
1
2012
610
0.080
Why?
Photopheresis
1
2009
12
0.080
Why?
Folic Acid
1
1989
63
0.080
Why?
Rad51 Recombinase
2
2021
81
0.080
Why?
Chromosomes, Human, Pair 1
2
2000
100
0.080
Why?
Predictive Value of Tests
3
2024
1741
0.080
Why?
Canada
1
2009
201
0.080
Why?
Clinical Protocols
2
2004
158
0.080
Why?
Ghrelin
1
2009
29
0.080
Why?
Maximum Tolerated Dose
3
2015
263
0.080
Why?
Insurance, Health, Reimbursement
1
2009
60
0.080
Why?
Spiro Compounds
1
2009
26
0.080
Why?
Carrier Proteins
2
2003
680
0.080
Why?
Parenteral Nutrition
2
1986
62
0.080
Why?
Drug Interactions
1
2009
244
0.080
Why?
Cytochrome P-450 CYP3A
1
2008
42
0.080
Why?
Autoimmunity
1
2010
172
0.080
Why?
Chromosome Mapping
4
2006
1074
0.080
Why?
Feasibility Studies
3
2007
791
0.080
Why?
Body Composition
1
2009
73
0.080
Why?
Muscular Atrophy
1
2009
47
0.080
Why?
Immunoglobulin G
2
2001
472
0.080
Why?
Wine
1
2008
6
0.080
Why?
Interferon-beta
1
2009
126
0.080
Why?
Decision Support Techniques
1
2010
170
0.080
Why?
Data Interpretation, Statistical
2
2016
303
0.080
Why?
Haplotypes
2
2008
638
0.080
Why?
Preventive Medicine
1
2008
18
0.080
Why?
Psychology, Social
1
2008
9
0.080
Why?
Insulin-Like Growth Factor I
1
2009
115
0.080
Why?
Curcumin
1
2008
18
0.070
Why?
Cell Proliferation
1
2014
1688
0.070
Why?
Lupus Erythematosus, Systemic
1
2010
211
0.070
Why?
Video Recording
3
2015
204
0.070
Why?
Taste
1
2008
28
0.070
Why?
Glycoproteins
1
1989
236
0.070
Why?
Rifamycins
1
2007
6
0.070
Why?
Tablets
1
2009
126
0.070
Why?
Transcriptome
1
2013
667
0.070
Why?
Cisapride
1
2007
4
0.070
Why?
Domperidone
1
2007
8
0.070
Why?
Growth
1
2007
43
0.070
Why?
HCT116 Cells
2
2021
158
0.070
Why?
Antifoaming Agents
1
2007
1
0.070
Why?
Thiazolidinediones
1
2007
74
0.070
Why?
Leukocyte Count
3
2003
224
0.070
Why?
Digestive System Physiological Phenomena
1
2007
4
0.070
Why?
Nutritional Requirements
1
2007
17
0.070
Why?
Taxes
1
2007
3
0.070
Why?
Salicylates
2
1999
25
0.070
Why?
Food Service, Hospital
1
2007
4
0.070
Why?
Vaccination
1
2009
280
0.070
Why?
Tumor Necrosis Factors
1
2007
14
0.070
Why?
Antigens, Neoplasm
1
1989
335
0.070
Why?
Cyclophosphamide
3
1996
303
0.070
Why?
Mass Screening
2
2008
646
0.070
Why?
Gases
1
2007
30
0.070
Why?
3',5'-Cyclic-AMP Phosphodiesterases
1
2006
8
0.070
Why?
Gastrointestinal Transit
1
2007
19
0.070
Why?
Organizations
1
2007
17
0.070
Why?
Narration
1
2007
17
0.070
Why?
Cyclic Nucleotide Phosphodiesterases, Type 4
1
2006
10
0.070
Why?
Computers, Handheld
1
2007
34
0.070
Why?
Intercellular Signaling Peptides and Proteins
1
2008
182
0.070
Why?
Cytotoxins
1
1986
16
0.070
Why?
Pregnancy Rate
1
2006
21
0.070
Why?
Intestinal Perforation
1
2007
36
0.070
Why?
Preoperative Care
1
1989
400
0.070
Why?
Metronidazole
2
2000
26
0.070
Why?
Health Facilities
1
2007
40
0.070
Why?
Neoplasm Grading
2
2018
377
0.070
Why?
Survival Analysis
3
2004
1499
0.070
Why?
Longitudinal Studies
3
2000
1085
0.070
Why?
Constipation
1
2007
67
0.070
Why?
Cyclooxygenase 2 Inhibitors
1
2006
33
0.070
Why?
Adsorption
1
2006
54
0.070
Why?
Medical Records
1
2007
120
0.070
Why?
Intestinal Absorption
1
2007
125
0.070
Why?
Energy Intake
1
2006
98
0.070
Why?
Endoscopy, Digestive System
3
2001
69
0.070
Why?
Health Status Indicators
1
2006
103
0.070
Why?
North America
3
2014
188
0.070
Why?
Sample Size
1
2006
125
0.070
Why?
Fat Emulsions, Intravenous
1
1986
15
0.070
Why?
Helicobacter Infections
1
2006
37
0.070
Why?
Vibrio parahaemolyticus
1
2005
2
0.070
Why?
Helicobacter pylori
1
2006
37
0.070
Why?
Alaska
1
2005
20
0.060
Why?
Ostreidae
1
2005
3
0.060
Why?
Sirolimus
1
2007
164
0.060
Why?
Health Education
1
2006
105
0.060
Why?
Regression Analysis
4
2010
591
0.060
Why?
Jews
2
2003
42
0.060
Why?
Integrin alpha Chains
1
2005
16
0.060
Why?
Bacterial Toxins
1
1986
115
0.060
Why?
Patient Care
1
2007
101
0.060
Why?
Emotions
1
2009
358
0.060
Why?
Mice
4
2024
11932
0.060
Why?
Recombinant Proteins
4
2000
1015
0.060
Why?
Chemistry, Pharmaceutical
1
2006
65
0.060
Why?
Pancreatitis
1
1986
87
0.060
Why?
Viscera
1
2005
18
0.060
Why?
Nuclear Proteins
1
2010
728
0.060
Why?
Illinois
1
2007
491
0.060
Why?
Laos
1
2005
4
0.060
Why?
Histocytochemistry
2
2017
130
0.060
Why?
Antineoplastic Agents, Alkylating
2
1996
134
0.060
Why?
Mesenteric Veins
1
2005
35
0.060
Why?
Paclitaxel
1
2007
484
0.060
Why?
Polymorphism, Single Nucleotide
3
2010
2421
0.060
Why?
Recombinant Fusion Proteins
2
1997
565
0.060
Why?
Equipment Design
1
2006
423
0.060
Why?
Fatty Liver
1
2006
99
0.060
Why?
Pregnancy Trimester, Third
1
2004
69
0.060
Why?
Cells, Cultured
3
2015
2892
0.060
Why?
Kaplan-Meier Estimate
3
2013
854
0.060
Why?
Combined Modality Therapy
4
1999
1708
0.060
Why?
HLA-DRB1 Chains
1
2004
25
0.060
Why?
Pancreatic Diseases
1
2024
53
0.060
Why?
Mucoproteins
1
2024
14
0.060
Why?
Matrix Metalloproteinase 14
1
2024
5
0.060
Why?
Research Subjects
1
2005
73
0.060
Why?
Lymphocyte Subsets
1
2024
66
0.060
Why?
Diagnostic Errors
1
2005
160
0.060
Why?
Absenteeism
1
2004
10
0.060
Why?
Lymphocyte Count
1
2024
99
0.060
Why?
Linkage Disequilibrium
2
2008
477
0.060
Why?
Primary Health Care
1
2007
356
0.060
Why?
Confidence Intervals
3
1994
220
0.060
Why?
Clinical Trials, Phase II as Topic
1
2004
167
0.060
Why?
Fever
1
2004
128
0.060
Why?
Bone Density
1
2005
211
0.060
Why?
Drainage
1
2004
166
0.060
Why?
Structure-Activity Relationship
1
2004
429
0.060
Why?
Proportional Hazards Models
3
2018
842
0.050
Why?
Fibroblast Growth Factor 10
1
2003
7
0.050
Why?
Exercise
1
2007
328
0.050
Why?
Risk
3
2011
656
0.050
Why?
Probability
1
2004
355
0.050
Why?
Administration, Intravenous
1
2023
56
0.050
Why?
Cell Cycle Proteins
1
2006
399
0.050
Why?
Infant
1
2010
3183
0.050
Why?
Etanercept
2
2001
33
0.050
Why?
Body Mass Index
1
2006
775
0.050
Why?
Saccharomyces cerevisiae Proteins
1
2006
294
0.050
Why?
Lymphocyte Activation
1
2006
756
0.050
Why?
Therapeutic Equivalency
1
2022
16
0.050
Why?
Informed Consent
1
2005
276
0.050
Why?
Leukemia, Monocytic, Acute
1
1982
14
0.050
Why?
Antibodies, Antinuclear
3
2007
85
0.050
Why?
Enzyme-Linked Immunosorbent Assay
1
2003
374
0.050
Why?
Age of Onset
4
2007
319
0.050
Why?
Syndrome
1
2003
452
0.050
Why?
Venous Thrombosis
1
2005
260
0.050
Why?
Methylprednisolone
1
2022
65
0.050
Why?
Multivariate Analysis
2
2020
982
0.050
Why?
ROC Curve
1
2024
781
0.050
Why?
Patient Compliance
4
2007
230
0.050
Why?
Survival Rate
3
2011
1899
0.050
Why?
Purpura, Thrombotic Thrombocytopenic
1
2002
18
0.050
Why?
Neovascularization, Pathologic
1
2024
354
0.050
Why?
Sex Factors
1
2005
1074
0.050
Why?
Plasma Exchange
1
2002
31
0.050
Why?
Lod Score
4
2006
152
0.050
Why?
Intention to Treat Analysis
1
2021
72
0.050
Why?
Bradycardia
1
2021
39
0.050
Why?
Ku Autoantigen
1
2021
12
0.050
Why?
Frameshift Mutation
1
2001
51
0.050
Why?
Aftercare
1
2022
87
0.050
Why?
Cyclosporins
1
2001
58
0.050
Why?
Real-Time Polymerase Chain Reaction
2
2013
285
0.050
Why?
Folic Acid Antagonists
1
2000
17
0.050
Why?
Statistics, Nonparametric
2
1999
303
0.050
Why?
Leukemia, Hairy Cell
1
1981
186
0.050
Why?
Peristalsis
1
2000
10
0.050
Why?
Coculture Techniques
1
2021
176
0.040
Why?
Suppositories
1
2000
3
0.040
Why?
Poly(ADP-ribose) Polymerase Inhibitors
1
2021
76
0.040
Why?
Mice, Inbred C57BL
2
2021
3273
0.040
Why?
Adaptation, Psychological
1
2021
166
0.040
Why?
Down-Regulation
2
2013
521
0.040
Why?
Decision Making
1
2006
672
0.040
Why?
Bacterial Proteins
1
1986
903
0.040
Why?
Chemical and Drug Induced Liver Injury
1
2000
65
0.040
Why?
Genetic Markers
3
2013
477
0.040
Why?
Salvage Therapy
2
2013
233
0.040
Why?
Data Collection
2
1999
377
0.040
Why?
Gene Expression
1
2024
1312
0.040
Why?
Databases, Genetic
1
2021
270
0.040
Why?
Interleukin-11
1
1999
20
0.040
Why?
Suture Techniques
1
2000
144
0.040
Why?
Cutaneous Fistula
1
1999
11
0.040
Why?
Hospitals
1
2022
308
0.040
Why?
Gene Expression Profiling
2
2017
1460
0.040
Why?
Xenograft Model Antitumor Assays
1
2021
491
0.040
Why?
Electromyography
1
1999
195
0.040
Why?
Hematopoietic Stem Cell Transplantation
2
1996
914
0.040
Why?
Patient Discharge
1
2022
327
0.040
Why?
Gene Expression Regulation, Neoplastic
2
2017
1286
0.040
Why?
Immunotherapy
1
2024
703
0.040
Why?
Chromosomes, Human, Pair 12
1
1998
65
0.040
Why?
Health Services
1
1999
56
0.040
Why?
Proctocolitis
1
1998
3
0.040
Why?
Chromosomes, Human, Pair 4
1
1998
47
0.040
Why?
Genetic Variation
2
2006
1382
0.040
Why?
Reference Standards
1
2018
143
0.040
Why?
Fatal Outcome
1
1998
298
0.040
Why?
Lipopolysaccharides
2
2014
295
0.040
Why?
Epistasis, Genetic
1
1998
90
0.040
Why?
Breast Neoplasms
3
1996
3019
0.040
Why?
Cost of Illness
1
1998
149
0.040
Why?
Transfection
2
2010
910
0.040
Why?
Monitoring, Ambulatory
1
1997
32
0.040
Why?
Opportunistic Infections
1
2017
60
0.040
Why?
Constriction, Pathologic
2
2006
222
0.040
Why?
Fatty Acids, Volatile
1
1997
33
0.040
Why?
Lipoxygenase Inhibitors
1
1997
34
0.040
Why?
Homeodomain Proteins
1
2021
558
0.030
Why?
Comorbidity
1
2000
955
0.030
Why?
Interleukin-3
1
1996
36
0.030
Why?
Quinolines
1
1997
87
0.030
Why?
International Agencies
1
2016
34
0.030
Why?
Diphenhydramine
1
1996
17
0.030
Why?
Occludin
1
2016
66
0.030
Why?
Interleukin-8
1
2016
86
0.030
Why?
Antibodies, Antineutrophil Cytoplasmic
1
1996
21
0.030
Why?
Delphi Technique
1
2016
105
0.030
Why?
Zonula Occludens-1 Protein
1
2016
70
0.030
Why?
Histamine H1 Antagonists
1
1996
40
0.030
Why?
Granulocyte-Macrophage Colony-Stimulating Factor
1
1996
112
0.030
Why?
Mice, Knockout
1
2021
2033
0.030
Why?
Prostaglandin Antagonists
1
1995
7
0.030
Why?
Hypertension
1
2021
746
0.030
Why?
Proteins
1
2001
797
0.030
Why?
Databases, Factual
1
1999
875
0.030
Why?
Immunity, Cellular
1
1996
179
0.030
Why?
Activities of Daily Living
1
2016
206
0.030
Why?
Enteral Nutrition
1
1996
105
0.030
Why?
Cadherins
1
2016
164
0.030
Why?
Pregnancy Outcome
1
2017
260
0.030
Why?
NF-kappa B
2
2013
469
0.030
Why?
Single-Blind Method
1
2015
152
0.030
Why?
Phytohemagglutinins
1
2014
21
0.030
Why?
Signal Transduction
2
2017
3426
0.030
Why?
Israel
1
2014
59
0.030
Why?
Antigens, CD
1
2016
467
0.030
Why?
Minnesota
1
1994
45
0.030
Why?
Interleukin-1beta
1
2014
82
0.030
Why?
CD28 Antigens
1
2014
89
0.030
Why?
Administration, Cutaneous
1
1994
60
0.030
Why?
Polymerase Chain Reaction
2
2010
923
0.030
Why?
Hematopoietic Stem Cells
1
1996
309
0.030
Why?
Microspheres
1
2014
108
0.030
Why?
Trinitrobenzenesulfonic Acid
1
2013
16
0.030
Why?
Dextran Sulfate
1
2013
69
0.030
Why?
Gene Frequency
2
2008
689
0.030
Why?
Radiation Dosage
1
2014
230
0.030
Why?
Area Under Curve
1
2014
338
0.030
Why?
Discriminant Analysis
1
2013
66
0.030
Why?
Adaptive Immunity
1
2014
167
0.030
Why?
Group Processes
1
2013
31
0.030
Why?
Tobacco Smoke Pollution
1
1993
25
0.030
Why?
Hydrocortisone
1
1994
302
0.030
Why?
Apoptosis Regulatory Proteins
1
2013
198
0.030
Why?
DNA, Complementary
1
2013
391
0.020
Why?
Tertiary Care Centers
1
2013
112
0.020
Why?
Tight Junctions
1
2013
151
0.020
Why?
Aneuploidy
1
1992
57
0.020
Why?
Transcriptional Activation
1
2013
295
0.020
Why?
Polymorphism, Restriction Fragment Length
1
2012
147
0.020
Why?
Myelodysplastic Syndromes
1
1995
361
0.020
Why?
Suspensions
1
2011
6
0.020
Why?
Anastomosis, Surgical
1
2013
277
0.020
Why?
Tumor Suppressor Proteins
1
2013
290
0.020
Why?
Regional Blood Flow
1
2011
198
0.020
Why?
Medication Adherence
1
2013
139
0.020
Why?
Metagenome
1
2012
106
0.020
Why?
Interdisciplinary Communication
1
2012
130
0.020
Why?
RNA, Ribosomal, 16S
1
2012
252
0.020
Why?
Tobacco Use Disorder
1
2012
116
0.020
Why?
Polymethacrylic Acids
1
1990
3
0.020
Why?
Chewing Gum
1
1990
4
0.020
Why?
In Situ Hybridization
1
2011
313
0.020
Why?
Oligonucleotide Array Sequence Analysis
1
2013
693
0.020
Why?
Sentinel Surveillance
1
2010
23
0.020
Why?
Polyvinyls
1
1990
17
0.020
Why?
Tumor Necrosis Factor alpha-Induced Protein 3
1
2010
15
0.020
Why?
Patient Safety
1
2013
218
0.020
Why?
Up-Regulation
1
2013
728
0.020
Why?
Protein Structure, Quaternary
1
2010
102
0.020
Why?
Statistics as Topic
1
2011
234
0.020
Why?
Immunoprecipitation
1
2010
139
0.020
Why?
Quality Improvement
1
2014
459
0.020
Why?
Immunoblotting
1
2010
272
0.020
Why?
Methoxsalen
1
2009
15
0.020
Why?
Mice, Transgenic
1
2013
1583
0.020
Why?
Blotting, Western
1
2011
794
0.020
Why?
Interferon beta-1a
1
2009
18
0.020
Why?
Epithelial Cells
1
2013
693
0.020
Why?
Photosensitizing Agents
1
2009
51
0.020
Why?
Cecum
1
1989
73
0.020
Why?
Evaluation Studies as Topic
1
1989
270
0.020
Why?
Motivation
1
2012
303
0.020
Why?
Immunoenzyme Techniques
1
1989
303
0.020
Why?
Electrolytes
1
1988
52
0.020
Why?
Registries
1
1993
812
0.020
Why?
Midazolam
1
2008
48
0.020
Why?
Headache
1
2009
74
0.020
Why?
Immunohistochemistry
1
2013
1805
0.020
Why?
Rabbits
2
2005
641
0.020
Why?
Japan
1
2008
305
0.020
Why?
Cross-Sectional Studies
1
2013
1735
0.020
Why?
Anal Canal
1
1988
90
0.020
Why?
Apoptosis
1
2013
1723
0.020
Why?
Sacroiliac Joint
1
2006
9
0.020
Why?
Nod1 Signaling Adaptor Protein
1
2006
2
0.020
Why?
Emulsions
1
1986
19
0.020
Why?
Rectal Diseases
1
2006
23
0.020
Why?
Stomach Diseases
1
2006
19
0.020
Why?
Duodenal Diseases
1
2006
23
0.020
Why?
Esophageal Diseases
1
2006
27
0.020
Why?
Uveitis
1
2006
31
0.020
Why?
JC Virus
1
2005
5
0.020
Why?
Influenza, Human
1
2009
341
0.020
Why?
Endpoint Determination
1
2005
55
0.020
Why?
Short Bowel Syndrome
1
2005
38
0.020
Why?
RNA, Messenger
1
2011
2030
0.020
Why?
Minority Groups
1
2006
152
0.010
Why?
Liver Function Tests
1
1985
93
0.010
Why?
Tissue Culture Techniques
1
2005
83
0.010
Why?
Drug Tolerance
1
2004
64
0.010
Why?
Intestine, Large
1
1984
15
0.010
Why?
Random Allocation
1
2005
327
0.010
Why?
Campylobacter Infections
1
1984
11
0.010
Why?
Diverticulum, Colon
1
1984
10
0.010
Why?
CD4-Positive T-Lymphocytes
1
2007
452
0.010
Why?
Drug Hypersensitivity
1
1984
37
0.010
Why?
Models, Animal
1
2005
278
0.010
Why?
Adaptor Proteins, Signal Transducing
1
2006
315
0.010
Why?
DNA-Binding Proteins
1
2010
1247
0.010
Why?
Physical Examination
1
1984
150
0.010
Why?
CD8-Positive T-Lymphocytes
1
2007
601
0.010
Why?
Software
1
2007
669
0.010
Why?
Cell Line, Tumor
1
2008
2607
0.010
Why?
Length of Stay
2
1996
756
0.010
Why?
Radiography
1
1984
809
0.010
Why?
Genome-Wide Association Study
1
2010
1692
0.010
Why?
Thyroxine
1
1984
361
0.010
Why?
Clostridium Infections
1
1984
125
0.010
Why?
Blastomycosis
1
1981
7
0.010
Why?
DNA Mutational Analysis
1
2003
528
0.010
Why?
Anticoagulants
1
2005
440
0.010
Why?
Mycobacterium Infections
1
1981
15
0.010
Why?
Cellulitis
1
1981
19
0.010
Why?
Splenectomy
1
1981
82
0.010
Why?
Hepatitis
1
1981
34
0.010
Why?
Patient Education as Topic
1
2004
364
0.010
Why?
Homozygote
1
2001
200
0.010
Why?
I-kappa B Proteins
1
2000
54
0.010
Why?
Abscess
1
1981
95
0.010
Why?
Mutagenesis, Insertional
1
2001
114
0.010
Why?
Injections
1
2001
116
0.010
Why?
Patient Dropouts
1
2000
30
0.010
Why?
Middle East
1
2000
18
0.010
Why?
Physical Chromosome Mapping
1
2000
27
0.010
Why?
Injections, Intramuscular
1
2000
64
0.010
Why?
Cytosine
1
2001
131
0.010
Why?
Heterozygote
1
2001
373
0.010
Why?
Family Health
1
2000
162
0.010
Why?
International Cooperation
1
2000
126
0.010
Why?
Lymphoma
1
1981
268
0.010
Why?
In Situ Hybridization, Fluorescence
1
2000
354
0.010
Why?
Protein Structure, Tertiary
1
2001
742
0.010
Why?
Pedigree
1
2000
969
0.010
Why?
Erythrocytes
1
1999
255
0.010
Why?
Alleles
1
2001
1138
0.010
Why?
Disease Models, Animal
1
2005
2407
0.010
Why?
Amino Acid Sequence
1
2001
2076
0.010
Why?
Disease Susceptibility
1
1998
200
0.010
Why?
Base Sequence
1
2001
2329
0.010
Why?
Leukotriene B4
1
1997
14
0.010
Why?
Cell Line
1
2001
2505
0.010
Why?
Colony-Forming Units Assay
1
1996
41
0.010
Why?
Molecular Sequence Data
1
2001
3029
0.010
Why?
Blood Cells
1
1996
33
0.010
Why?
Bone Marrow Diseases
1
1996
40
0.010
Why?
Thiotepa
1
1996
32
0.010
Why?
Life Tables
1
1996
47
0.010
Why?
Premedication
1
1996
57
0.010
Why?
Thrombophlebitis
1
1995
25
0.010
Why?
Surgical Wound Dehiscence
1
1995
37
0.010
Why?
Melphalan
1
1996
99
0.010
Why?
Karyotyping
1
1995
252
0.010
Why?
Doxorubicin
1
1996
293
0.010
Why?
Insurance Selection Bias
1
1995
1
0.010
Why?
Leukemia, Myeloid, Acute
1
1981
802
0.010
Why?
Bone Marrow Transplantation
1
1996
286
0.010
Why?
Substance Withdrawal Syndrome
1
1995
47
0.010
Why?
Fluorouracil
1
1996
548
0.010
Why?
Chromosome Aberrations
1
1995
384
0.010
Why?
Palliative Care
1
1996
264
0.010
Why?
Surgical Wound Infection
1
1995
205
0.010
Why?
Genotype
1
1998
1855
0.010
Why?
Disease-Free Survival
1
1996
1170
0.010
Why?
Orosomucoid
1
1991
1
0.010
Why?
Antineoplastic Agents
1
1981
2337
0.010
Why?
Cyclic GMP
1
1988
62
0.000
Why?
Cyclic AMP
1
1988
278
0.000
Why?
Infant, Newborn
1
1993
2501
0.000
Why?
Alanine Transaminase
1
1985
72
0.000
Why?
Aspartate Aminotransferases
1
1985
75
0.000
Why?
Alkaline Phosphatase
1
1985
132
0.000
Why?
Bilirubin
1
1985
131
0.000
Why?
Blastomyces
1
1981
3
0.000
Why?
B-Lymphocytes
1
1983
741
0.000
Why?
Skin
1
1981
590
0.000
Why?
Hanauer's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (935)
Explore
_
Co-Authors (40)
Explore
_
Similar People (60)
Explore
_
Same Department Expand Description
Explore
_
Physical Neighbors
_